OK Biotech Co Ltd operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares OK Biotech Co Ltd with three other
pharmaceutical manufacturers in Asia:
BioSino Bio-technology and Science Inc
sales of 295.13 million Chinese Renmimbi [US$46.72 million]
Kainos Laboratories, Inc.
(4.70 billion Japanese Yen [US$43.27 million]
of which 52%
was immunological business), and
Mizuho Medy Co Ltd
based in Japan
(5.62 billion Japanese Yen [US$51.75 million]
OK Biotech Co Ltd reported sales of 1.23 billion Taiwanese Dollars (US$41.64 million)
December of 2017.
increase of 18.5%
versus 2016, when the company's sales were 1.04 billion Taiwanese Dollars.
This was the third consecutive year of growth at OK Biotech Co Ltd.